Evidence map›Paper›PMID 30425813›Full record

ArticleGastroenterology and hepatology from bed to bench2018

Designing a novel ELISA method based on

Farideh Kamarehei, Alireza Khabiri, Massoud Saidijam, Meysam Soleimani, Mohammad Yousef Alikhani

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Gastroenterology and hepatology from bed to bench, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. The Effect ofIranian journal of public health · 2022
    Review
  2. The use of exosome carrier to augmentation ofStem cell investigation · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Farideh KamareheiDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Alireza KhabiriDiagnostic Biotechnology Unit, Research and Production Complex, Pasteur Institute of Iran, Tehran, Iran.
Massoud SaidijamResearch Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Meysam SoleimaniDepartment of Pharmaceutical Biotechnology, Hamadan University of Medical Sciences, Hamadan, Iran.
Mohammad Yousef AlikhaniDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimIn this research, we designed a direct Enzyme Linked Immunoassay method to detect

background

methodsWe produced and purified recombinant

resultsThe sensitivity and specificity of assay was determined as 91.7 [95% confidence interval: 89.3-95.6%] and 93.1% [95% CI: 91.2-96.4%], respectively. Novel ELISA exhibits enhanced sensitivity and specificity of

conclusionCombination of the recombinant antigens and whole cell of

Indexed as

CagA proteinEnzyme-linked immunosorbent assayHelicobacter pyloriNeutrophil activating protein A

Identifiers

PMID30425813
PMCPMC6204246
OpenAlexW2897023536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.